Mitchell Gold
Executive Chairman and CEO, Director at Alpine Immune Sciences, Inc. (ALPN)
Mitchell Gold has filed 19 insider reports with the SEC since February 2021, as executive Chairman and CEO and director at Alpine Immune Sciences, Inc. (ALPN). Mitchell Gold made no open-market purchases or sales in the last 12 months. The latest filing, on May 21, 2024, reports sale back to the company and tender of shares in a change of control at Alpine Immune Sciences, Inc. (ALPN).
- Filings
- 19
- Companies
- 1
- Bought on market
- None
- Sold on market
- $10.1M
Companies where Mitchell Gold is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Executive Chairman and CEO, Director | 0 | $10.1M | May 21, 2024 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- May 20, 2024ALPNGold Mitchell returned 109,245 shares to the company, closing all direct ownership in the companyForm 4Sale back to the companyTender of shares in a change of control
- May 8, 2024ALPNGold Mitchell exercised 13,245 shares at a strike of $7.55, increasing direct ownership by 14% to 109,245 unitsForm 4Exercise or conversion of a derivative
- Jan 4, 2024ALPNGold Mitchell was granted 96,000 sharesForm 4Grant or award
- Dec 28, 2023-$20.4KALPNGold Mitchell exercised 75,457 shares at a strike of $12.58, sold $20,362 worth of shares (1,016 units at $20.04) and covered exercise/tax liability with 48,264 sharesForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Dec 27, 2023-$1.86MALPNGold Mitchell exercised 91,884 shares at a strike of $0.56 and sold $1,860,528 worth of shares (91,884 units at $20.25)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Dec 19, 2023-$48.1KALPNGold Mitchell exercised 2,402 shares at a strike of $0.45 and sold $48,064 worth of shares (2,402 units at $20.01)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Dec 19, 2023~$2.4MALPNMitchell Gold plans to sell 120,000 shares (~$2.4M)Form 144Planned sale10b5-1 plan
- Dec 12, 2023-$2.04MALPNGold Mitchell sold $2,037,837 worth of shares (118,000 units at $17.27) and exercised 8,613 shares at a strike of $0.45, closing all direct ownership in the companyForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Dec 8, 2023~$1.99MALPNMitchell Gold plans to sell 118,000 shares (~$1.99M)Form 144Planned sale10b5-1 plan
- Jan 4, 2023ALPNSEC Form 4 filed by Gold MitchellForm 4Grant or award
- Jan 4, 2022ALPNSEC Form 4 filed by Gold MitchellForm 4Grant or award
- Sep 17, 2021-$4.21MALPNSEC Form 4: Gold Mitchell sold $4,212,964 worth of Common Stock (445,262 units at $9.46), decreasing direct ownership by 29% to 109,387 unitsForm 4Open-market sale10b5-1 plan
- Sep 16, 2021-$103KALPNSEC Form 4: Gold Mitchell sold $102,536 worth of Common Stock (10,252 units at $10.00), decreasing direct ownership by 6% to 154,649 unitsForm 4Open-market sale10b5-1 plan
- Jun 28, 2021-$130KALPNSEC Form 4: GOLD MITCHELL sold $129,657 worth of Common Stock (12,952 units at $10.01), decreasing direct ownership by 7% to 164,901 unitsForm 4Open-market sale10b5-1 plan
- May 20, 2021-$784KALPNSEC Form 4: GOLD MITCHELL sold $784,233 worth of Common Stock (52,186 units at $15.03), decreasing direct ownership by 23% to 177,853 unitsForm 4Open-market sale10b5-1 plan
- May 13, 2021-$232KALPNSEC Form 4: GOLD MITCHELL sold $232,011 worth of Common Stock (20,000 units at $11.60), decreasing direct ownership by 8% to 230,039 unitsForm 4Open-market sale10b5-1 plan
- Apr 14, 2021-$206KALPNSEC Form 4: GOLD MITCHELL sold $205,914 worth of Common Stock (20,000 units at $10.30), decreasing direct ownership by 7% to 250,039 unitsForm 4Open-market sale10b5-1 plan
- Mar 5, 2021-$260KALPNSEC Form 4: Mitchell Gold sold $259,983 worth of Common Stock (20,000 units at $13.00), decreasing direct ownership by 7% to 270,039 unitsForm 4Open-market sale10b5-1 plan
- Feb 2, 2021-$246KALPNSEC Form 4: Mitchell Gold sold $246,046 worth of Common Stock (20,000 units at $12.30), decreasing ownership by 6% to 290,039 unitsForm 4Open-market sale10b5-1 plan
Compare Mitchell Gold with
- Mitchell Gold vs Christopher Peetz1 shared
- Mitchell Gold vs Natasha Hernday1 shared
- Mitchell Gold vs Jorn Drappa1 shared
- Mitchell Gold vs Robert E Conway1 shared
- Mitchell Gold vs James N Topper1 shared
- Mitchell Gold vs Peter A. Thompson1 shared
Questions about Mitchell Gold
- What is Mitchell Gold's role at Alpine Immune Sciences, Inc.?
- Mitchell Gold reports to the SEC as executive Chairman and CEO and director at Alpine Immune Sciences, Inc. (ALPN), according to the latest filing on May 21, 2024.
- Has Mitchell Gold bought or sold stock recently?
- The most recent open-market sale was on December 28, 2023: sold 1,016 shares of Alpine Immune Sciences, Inc. (ALPN) for $20.4K at an average of $20.04.
- How do I get alerts when Mitchell Gold files?
- Follow Mitchell Gold on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Mitchell Gold (SEC CIK 0001242882). Totals count each trade once, skipping amendments whose original is on file, from Feb 3, 2021 on. View on SEC EDGAR